An observational study in Cardiovascular Diseases, Hypertension and Blood Pressure, sponsored by Stanford University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Stanford University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Hypertension by Stanford University — 1 open to participants now, 2 under way, none of them phase 3. Hypertension · Stanford University.
Among the 18 studies in Hypertension by Stanford University, this one is the only one that started in 2026, is one of 3 observational ones, and was the 18th registered.
6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.
Browse Hypertension studies →1 of the 18 studies in Hypertension by Stanford University is open now, in 1 country. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 30–90
By country, each count listing its studies:
Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.
This study: 18 Years to 64 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 1978; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 352 across 1,166 observational studies indexed under Hypertension.
Median enrollment 90 across the 14 interventional studies, 1,277 across the 2 observational. Of the 16 that completed or were terminated, 2 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Hypertension by Stanford University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device.
6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.
This study's planned enrollment of 50 is below the median of 352 across 1,166 observational studies indexed under Hypertension.
Browse Hypertension studies →Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
Compared within Hypertension, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Cardiovascular Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Participants with a range of health conditions are needed for this study, including those with cardiac or blood pressure issues, as well as individuals who are considered healthy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood pressure cuff, an EKG, and a PPG will be utilized to collect subject vitals.
Collection of Subject Name (optional)
Time frame: Less than 1 minute
Collection of Subject Height
Height in meters
Time frame: Less than 1 minute
Collection of Subject Weight
Weight in kilograms
Time frame: Less than 1 minute
Collection of Subject Age
Age in years
Time frame: Less than 1 minute
Collection of Subject Medical Comorbidities
Time frame: 1 minute
Systolic and Diastolic Blood Pressure Measurement
Using blood pressure cuff; measured three times to find the initial, interim, and final blood pressure
Time frame: 1-2 minutes
Collection of ECG Waveforms
Using an electrocardiogram (ECG) to measure heart rhythm
Time frame: 5 minutes
Collection of PPG Waveforms
Using a photoplethysmography (PPG) to monitor heart rate
Time frame: 5 minutes
Ran from May 2026 to primary completion in Aug 2026, 3 months.
Of 348 non-industry observational studies under Hypertension, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 111. This study's 3 months is below that.
Counting every sponsor, half of 429 studies reached it within 38 months; a quarter within 17 and three quarters within 96.
Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Sep 2026 → Aug 2026 and completion Sep 2026 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.